COMPOSITIONS AND METHODS FOR TREATING RETINITIS PIGMENTOSA

TREATMENT OF LIMB SPASTICITY

METHODS OF TREATING SJOGREN'S DISEASE

Method of Treating Severe Asthma

CHIMERIC PROTEINS COMPRISING MEMBRANE BOUND IL-12 WITH PROTEASE CLEAVABLE LINKERS

COMPOUNDS FOR TREATMENT OF EXCITOTOXICITY

ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER

SYSTEMS AND METHODS FOR PROMOTING ANGIOGENESIS

COMPOSITIONS AND METHODS FOR TREATING AGING-RELATED METABOLIC AND NEUROLOGICAL DISORDERS

PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS

RSV RNA VACCINES

RECOMBINANT APYRASE PROTEIN FOR USE IN THE TREATMENT OF AN ISCHEMIC EVENT AT A DOSE OF 40-240 MG

TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA

Composition of GLP-1 and PYY3-36 Polypeptide Analogues, and Preparation Method and Use Thereof

ISCHEMIA/REPERFUSION INJURY

ACTIVATED STEM CELLS AND SYSTEMIC TREATMENT METHODS FOR INFECTED WOUNDS

METHODS FOR TREATING HEPATITIS B INFECTION

Targeted LNP-mRNA with Minimal Off-target Expression and Methods of use Thereof

Compositions and Devices for Systemic Delivery of Uridine

FORMULATIONS OF BRINCIDOFOVIR

CANNABIDIOL COMPOSITIONS FOR USE IN TREATING HEART CONDITIONS

Use of Tetramethylpyrazine Nitrone Derivatives In The Treatment of Ischemic Stroke

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, PREVENTING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

COMPOSITIONS COMPRISING A BENZENE SULFONAMIDE THIAZOLE COMPOUND

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

GLUTATHIONE-RESPONSIVE METHOTREXATE POLYMERSOMES FOR MANAGEMENT OF ECTOPIC PREGNANCY

RECOMBINANT OPCML FUSION PROTEIN OPTIMIZING OPCML D1 DOMAIN HOMODIMERISATION AND METHODS OF USE FOR CANCER TREATMENT

COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES

COMPOSITIONS AND METHODS FOR TREATING ACROMEGALY

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

Long-Acting Formulations of Insulin

PHARMACEUTICAL COMPOSITION COMPRISING ECHINOCANDIN ANALOG AND PREPARATION METHOD FOR PHARMACEUTICAL COMPOSITION

Peptide Amide Composition and Preparation Method Therefor

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS

HYDROGEL FOR BODY CAVITY INJURY TREATMENT AND BODY CAVITY INJURY TREATMENT KIT

METHODS OF TREATING BACILLUS CALMETTE-GUÉRIN (BCG)-NAÏVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC)

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS

COMPOSITION FOR PREVENTING OR TREATING PERIPHERAL NEUROPATHY, CONTAINING ISOQUINOLINE DERIVATIVE AS ACTIVE INGREDIENT

Dosing Regimens for Treatment of Glioblastoma

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies

PRE-MEDICATION AND IMPROVED TREATMENT REGIMEN

LONG ACTING ALPHA4BETA7 TARGETING MOLECULE COMPOSITIONS FOR THE TREATMENT GASTROINTESTINAL INFLAMMATORY DISEASE

ANTI-CTLA-4 ANTIBODY DOSING REGIMENS

COMBINATION THERAPY OF A GPRC5D TCB AND CD38 ANTIBODIES

PHARMACEUTICAL COMPOSITION CONTAINING FUSION PROTEIN

STABILIZED FORMULATIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES

Spiropyrrolidine Derived Antiviral Agents

TRIFUNCTIONAL COMPOUND AND USE THEREOF

FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF

MIXED VASOPRESSIN RECEPTOR AGONIST-ANTAGONIST FOR MODULATING MEAN ARTERIAL PRESSURE

FLUORESCENT COMPOUNDS FOR SYNERGISTIC PHOTODYNAMIC AND PHOTOTHERMAL CANCER THERANOSTIC

ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

NUCLEIC ACID MOLECULES AND USES THEREOF

INJECTION COMPOSITION FOR LIPOLYSIS

DAPTOMYCIN COMPOSITIONS

POLYNUCLEOTIDES FOR SILENCING TRANSCRIPT VARIANT 1 OF ASSEMBLY FACTOR FOR SPINDLE MICROTUBULES AND APPLICATIONS THEREOF

METHODS AND COMPOSITIONS FOR INHIBITION OF POLYMERASE

SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND RELATED METHODS

METHOD OF ADMINISTERING SOTALOL HYDROCHLORIDE FOR THE TREATMENT OF PEDIATRIC PATIENTS

Novel Lipids For Delivery Of Nucleic Acid Segments

DELIVERY OF THERAPEUTIC PROTEINS

DRUG-LOADED BIODEGRADABLE MICROBEAD COMPOSITIONS INCLUDING DRUG-CONTAINING VESICULAR AGENTS

MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS

PREPARATIONS AND METHODS FOR TREATING A GD2 POSITIVE CANCER

CLINICALLY PROVEN SUBCUTANEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND THEIR USES IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE

ANTI-IL-2 ANTIBODY COMBINATIONS AND METHODS OF USE THEREOF

METHODS FOR MODULATING ACTIVITY OF IL-18 FOR TREATMENT OF CD4+ T CELL MEDIATED AUTOIMMUNITY AND IMMUNOPATHOLOGY

T CELL RECEPTORS DIRECTED AGAINST MELANOMA-ASSOCIATED ANTIGEN AND USES THEREOF

ENGINEERED IMMUNOCYTOKINES, FUSION POLYPEPTIDES, AND IL10 POLYPEPTIDES

REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS

HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS

INJECTABLE THERMORESPONSIVE HYDROGELS AS A COMBINATORY MODALITY FOR CONTROLLED DRUG DELIVERY, BIOMATERIAL IMPLANT AND 3D PRINTING BIOINK

TREATMENT AND PREVENTION OF OSTEOPOROSIS IN HIGH BODY MASS INDEX INDIVIDUALS

COLLAGEN 7 COMPOSITIONS AND METHODS OF USING THE SAME

PHARMACEUTICAL COMPOSITION AND USE THEREOF

PRALATREXATE AND COP COMBINATION FOR THE TREATMENT OF PATIENTS WITH PERIPHERAL T CELL LYMPHOMA

LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND A PROCESS FOR PREPARATION

SUSTAINED-RELEASE INJECTABLE COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE, AND METHOD FOR PREPARING SAME

PLINABULIN MICELLE COMPOSITION AND PREPARATION METHOD THEREFOR

METHODS AND COMPOSITIONS FOR CENTRAL NERVOUS SYSTEM (CNS) DRUG DELIVERY AND TREATMENT

IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM

TREATMENT OF LUPUS

DOWN TITRATION LOADING OF SOTALOL INTRAVENOUSLY

OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF

APPLICATION OF DHA@ZIF-8 IN TREATMENT OF EXPERIMENTAL CEREBRAL MALARIA

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

INJECTABLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BREAST CANCER

CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION

MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF

THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)

METHOD OF TREATING NEURODEGENERATIVE DISEASES

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RADIATION INDUCED TOXICITY

METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS

COMPOSITIONS COMPRISING DISODIUM LEVOFOLINATE

KETAMINE FORMULATION

INJECTABLE LYOPHILIZED FORMULATION INCLUDING BETA-NICOTINAMIDE MONONUCLEOTIDE AND INJECTABLE FORMULATION INCLUDING THE SAME AND METHODS OF PREPARING THEM

IMMUNOTHERAPY

METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

USES OF OMALIZUMAB

METHODS OF TREATING THYROID EYE DISEASE

Methods of Performing Boron Neutron Capture Therapy (BNCT) in Combination with Immune Checkpoint Inhibitors to Enhance BNCT and the Anti-tumor effects of Immune Check Point Inhibitors as well as the Abscopal Effect Induced by Radiation Therapy and Methods Thereof

METHODS OF TREATING MELANOMA USING AN ANTI-CTLA4 ANTIBODY

AZAINDOLE ROCK INHIBITORS

HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE

TREATMENT OF CNS TUMORS

[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

INFLAMMATORY CONDITION-SPECIFIC DRUG-RELEASING HYDROGEL FOR OCULAR INJECTION

CDH17-BINDING ANTIBODIES AND METHODS OF USE THEREOF

PTH Treatment Regimen Comprising Two PTH Compounds

Hyaluronidase Enzyme Formulations for High Volume Administration

Dry Pharmaceutical Formulations of CNP Conjugates

INJECTABLE NUTRIENT SOLUTION

METHODS FOR TREATING COCCYGEAL, HIP, THIGH, OR LEG PAIN WITH HYALURONIC ACID

METHODS OF TREATING MYELODYSPLASTIC SYNDROME

SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS

POTENTIAL THERAPEUTICS FOR FIBROSIS BY BLOCKING THE INCREASE OF A KEY ENZYME

DOSING REGIMEN FOR INJECTABLE CETIRIZINE

THERAPEUTIC DRUG COMBINATIONS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

FORMULATIONS CONTAINING ACETAMINOPHEN AND SULFOALKYL ETHER CYCLODEXTRIN

INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT

INJECTABLE COMPOSITIONS

METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE PREPARATION

METHODS OF TREATING CANCER USING SUBCUTANEOUS DOSING OF MOSUNETUZUMAB AS A MONOTHERAPY OR IN COMBINATION WITH LENALIDOMIDE

COMPOUNDS, DEVICES, AND USES THEREOF

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

AAV CAPSID VARIANTS AND USES THEREOF

CATIONIC LIPID COMPOSITIONS FOR TISSUE-SPECIFIC DELIVERY

NON-PEGYLATED LIPID NANOPARTICLES

BETA-PEPTIDES AND BETA-PEPTIDE HYDROGELS

FORMULATIONS WITH REDUCED DEGRADATION OF POLYSORBATE

PHARMACEUTICAL FORMULATIONS

COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS

COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACID

INJECTABLE FORMULATIONS

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME

COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE

Innate Targeting of Adoptive Cellular Therapies

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER

METHODS OF TREATING HIGH RISK MULTIPLE MYELOMA

METHODS OF TREATING HIGH RISK MULTIPLE MYELOMA

PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

Liquid Pharmaceutical Formulations for an Anti-IL-1beta Antibody

METHODS AND COMPOSITIONS FOR PRODUCING A THERAPEUTIC FIELD EFFECT

Tumor-Associated Antigen Based Cancer Vaccine

USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA

NOVEL FORMULATIONS

PHARMACEUTICAL FORMULATIONS

COMPOSITIONS AND METHODS FOR MARCO INHIBITION AND IMPROVED DRUG DELIVERY

USE OF PLATELET-BASED PRODUCTS FOR TREATMENT OF CAPSULAR CONTRACTURE PROXIMATE BREAST IMPLANT

USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE

Treatment of Alcoholic Hepatitis

ADMINISTRATION OF TESTOSTERONE COMPOSITIONS

COMPOSITIONS COMPRISING FLUMAZENIL AND NALTREXONE AND METHODS FOR USE THEREOF

PHARMACEUTICAL COMPOSITION FOR DISRUPTING TUMOR BLOOD VESSELS

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS

USE OF DIHYDROTANSHINONE I DERIVATIVE IN PREPARATION OF DRUG FOR TREATING CEREBRAL CAVERNOUS MALFORMATION

METHODS OF TREATING BACTERIAL INFECTIONS

NANO2 DODECAFLUOROPENTANE EMULSION AS A CARDIAC ARREST THERAPEUTIC

INJECTABLE EMULSION FORMULATIONS OF CLEVIDIPINE

IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS

DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS

Hydrolyzed Pea Protein-Based Nutrient Composition

DOSAGES OF EMACTUZUMAB

METHOD FOR TREATING MEMBRANOUS NEPHROPATHY WITH TACI-FC FUSION PROTEIN

PRODUCTION OF RECOMBINANT LUBRICIN

GENE EDITING-BASED METHOD OF ATTENUATING THE BETA-AMYLOID PATHWAY

PHARMACEUTICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF METABOLIC AND LIVER DISORDERS

Antibody Compositions and Methods of Use Thereof

ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

Methods for the Rapid Manufacture of Conjugate Vaccines that Elicit Robust Immune Responses

Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents

AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

COMPOUND EMULSION, PREPARATION METHOD THEREFOR, AND USE THEREOF

Methods of Treating Myeloproliferative Neoplasms

COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR

SERIES OF POLYMERS HAVING PROPERTIES OF ACID-SENSITIVE DEGRADATION AND TEMPERATURE SENSITIVITY AND DRUG LOADING COMPOSITION THEREOF

PREPARATIONS AND METHODS FOR TREATING A GD2 POSITIVE CANCER

USE OF ANTI-CTLA-4 ANTIBODIES FOR TREATING ADENOID CYSTIC CARCINOMA

SUSPENSION CONTAINING RADIOACTIVE MICROSPHERES, AND PREPARATION METHOD THEREFOR AND USE THEREOF

USING ENHO GENE THERAPY TO TREAT CARDIOMETABOLIC DISEASE

PRODUCTS AND METHODS FOR USE IN TREATING NDP-RELATED DISEASES

INJECTABLE FORMULATIONS OF PARP INHIBITORS AND USES THEREOF

ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN

CORONAVIRUS VACCINE

NUCLEIC ACID VACCINES

BUNYAVIRALES VACCINE

COMBINATION TREATMENT REGIMES FOR TREATING CANCER

NEUROTOXIN COMPOSITIONS FOR USE IN TREATING GASTROPARESIS

Methods Of Treating Plantar Fibromatosis

NOVEL USE OF ONCOLYTIC VIRUS

ANTI-AGING COMPOSITIONS AND USES THEREOF

AMORPHOUS SOLID DISPERSIONS

HIGH-DOSE NALOXONE FORMULATION

METHODS OF TREATMENT OF TEMOZOLOMIDE-RESISTANT GLIOMA USING COENZYME Q10

COMPOSITIONS AND METHODS OF DELIVERING LARGE PROTEINS

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS

ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT

CONJUGATES COMPRISING BIS-MSPT LINKER

High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease

FORMULATION FOR STIMULATING HAIR GROWTH AND IMPROVING QUALITY AND METHOD OF PREPARATION OF THE SAME

COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), FOR EXAMPLE, MILD TRAUMATIC BRAIN INJURY (mTBI)

PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASE, NEURONAL MIGRATION PROMOTER, AND USE THEREOF

STABLE LIQUID BORTEZOMIB FORMULATIONS

PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, A PREPARATION METHOD, AND AN APPLICATION THEREOF

METHODS OF TREATING EYE DISORDERS

TINOSTAMUSTINE FOR USE IN THE TREATMENT OF T-CELL PROLYMPHOCYTIC LEUKAEMIA

DEXTROAMPHETAMINE AND LISDEXAMFETAMINE TO REVERSE DEXMEDETOMIDINE SEDATION

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

PROTEIN NANOSPHERES AND METHOD TO TREAT DYSFUNCTION FROM CHEMOTHERAPY AND IMMUNOSUPPRESSIVE THERAPY

FORMULATIONS OF SPRAY DRIED LIPID NANOPARTICLES

FORMULATIONS AND DOSAGE AMOUNTS FOR ADMINISTERING AN ANTI-DPP3 ANTIBODY OR FRAGMENT THEREOF TO HUMANS

ADENOVIRUS FORMULATIONS

INTRATHECAL ADMINISTRATION OF T REGULATORY CELLS IN THE TREATMENT OF MULTIPLE SCLEROSIS

GENE THERAPY FOR CEROID LIPOFUSCINOSES

Carboxyalkyl Chitosan

ANTI-TL1A ANTIBODY THERAPEUTIC METHODS

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

SYSTEMS AND METHODS FOR PRECISION DOSE DELIVERY, STERLIZATION, AND PACKAGING OF MEDICAL DEVICES

IMMUNIZATION METHOD AGAINST INFECTION BY SARS-CoV-2

SIALYLATED GLYCOPROTEIN COMPOSITION AND USES THEREOF

PRESERVATION OF PANCREATIC ISLET GRAFTS IN THE EXTRAHEPATIC SPACE

INJECTABLE HYDROGEL FOR PET ENDOMETRITIS, AND PREPARATION METHOD AND USE THEREOF

LONG-ACTING LIPOSOMAL COMPOSITION FOR TREATMENT OF PAIN IN ARTICULAR DISORDERS

COMPOSITION FOR THE TREATMENT OF COVID-19

COMPOSITION FOR THE TREATMENT OF COVID-19

COMPOSITIONS FOR NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR

METHODS FOR TREATMENT OF DISEASES

ANTIDIABETIC MEDICATIONS

METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA

METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY

TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS

STABLE LEVOTHYROXINE COMPOSITIONS IN APROTIC POLAR SOLVENTS

EPINEPHRINE FORMULATIONS

COMPOSITION AND PROCESS FOR A LIPID NANO-PARTICLE DELIVERY OF OXYGEN AND VITAL METABOLIC COMPOUNDS FOR HEMORRHAGIC SHOCK

COMPOSITIONS AND METHODS COMPRISING LIPID NANOPARTICLE VACCINES THAT ELICIT A MODULATED IMMUNE RESPONSE

LIQUID, STORAGE STABLE, DIRECTLY INJECTABLE, PANTOPRAZOLE FORMULATIONS, THEIR USES AND MANUFACTURING

ANTI-IGF-1R ANTIBODY COMPOSITIONS

IL-12 GENE THERAPY AND ANTI-VEGF COMBINATION FOR TREATING CANCER

BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM

LOCO-REGIONAL PERFUSION OF A KIDNEY

Drug Compounds Comprising Albumin-Binding Moieties

METHOD OF TREATING CANCER

MODIFIED T-CELLS FOR USE IN THE TREATMENT OF HEAD AND NECK CANCER

PHARMACEUTICAL COMPOSITION FOR PREVENTING HEPATITIS B VIRUS INFECTION AND USE THEREOF

NUCLEIC ACID VACCINES ENCAPSULATED WITH NANOALUMINOSILICATE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV)

COMPOSITION AND METHODS FOR REGULATING CHONDROCYTE PROLIFERATION AND INCREASING OF CARTILAGE MATRIX PRODUCTION

TREATMENT OF CONNECTIVE TISSUE INJURIES

COMPLEMENT INHIBITOR DOSING REGIMENS

ENCAPSULATED CANNABINOID FORMULATIONS FOR TRANSDERMAL DELIVERY

METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS

Pentagalloyl glucose (PGG) for use in treatment of pulmonary hypertension

IMMUNOTHERAPEUTIC PHOSPHOLIPIDS FOR CANCER TREATMENT

METHODS FOR TREATING CANCER

Pharmaceutical Combinations For The Treatment Of Cancer

COMPOSITIONS AND METHODS FOR THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS

METHODS OF TREATING PRIMARY LIVER TUMORS WITH NATURAL KILLER CELLS EXPRESSING A CYTOTOXIC RECEPTOR COMPLEX

USE OF MULTITARGETED POLYPEPTIDE IN TREATMENT OF ORGAN FIBROSIS

Pharmaceutical Formulation and Dosing Regimen for the Treatment of Amyotrophic Lateral Sclerosis

ANTI-PD-1 ANTIBODIES, OR FRAGMENTS THEREOF, FOR TREATING HEPATITIS B

BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE

POLYMORPHIC FORM OF NEPICASTAT ACID ADDITION SALT, PREPARATION METHOD THEREFOR AND USE THEREOF

GENETIC CONSTRUCTS FOR GENE EDITING

Multi-Functional Nanoparticle System for Delivery of NAD+ Precursors, Sirtuin Activators, Senolytic Agents, and Stem Cells with pH-Responsive Release

POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

SYNTHETIC ONCOLYTIC LNP-REPLICON RNA AND USES FOR CANCER IMMUNOTHERAPY

ALLOGENEIC MESENCHYMAL STEM CELLS FOR THE TREATMENT OF RETINAL DISORDERS ASSOCIATED WITH THE PRESENCE OF DRUSEN

PLATELET-RICH PLASMA COMPOSITIONS, PREPARATION, AND USES THEREOF

Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations

METHODS OF TREATING RHEUMATIC DISEASES USING TRIMETAZIDINE-BASED COMPOUNDS

METHODS AND COMPOSITIONS FOR TREATING SEPSIS

Phenylephrine Hydrochloride Compositions and Containers

METHOD FOR PRODUCING NONHUMAN PRIMATE ANIMAL MODEL OF CEREBRAL INFARCTION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION

CRISPR/CAS9-BASED REPRESSORS FOR SILENCING GENE TARGETS IN VIVO AND METHODS OF USE

ANTIBODY FORMULATIONS

TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES

FORMULATIONS COMPRISING ACTRIIA PROTEIN VARIANTS

MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA

PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT

AAV VECTOR FOR TREATMENT OF FRIEDREICH'S ATAXIA

ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS WITH IMPROVED RETINAL TRANSDUCTION AND USES THEREOF

OXIDIZED CARBON PEG-OAC NANOZYMES FOR MITOCHONDRIAL DISORDERS

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS

USE OF VIRUS-LIKE PARTICLES IN VACCINATION

PHARMACEUTICAL COMPOSITIONS AND THEIR USES, AND METHODS FOR IMPROVING THE STORAGE STABILITY OF PHARMACEUTICAL COMPOSITIONS

GIP/GLP1 AGONIST COMPOSITIONS

PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS